Biopharmaceutical Contract Manufacturing Market Value of US$ 18.7 Billion by 2029, at a CAGR of 10.5% from 2022 to 2029
Germany is set to exhibit a CAGR of over 11.5% in the European biopharmaceutical contract manufacturing market during the forecast per..
Research Reports